Huntington Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This locus is closely linked to Huntington disease and has been mapped to chromosome 4 short arm using human-mouse somatic cell hybrids, and specifically to chromosome 4 band p16 using DNA from individuals with deletions of chromosome 4 short arm who exhibit Wolf-Hirschhorn syndrome.
|
2876628 |
1986 |
Wolf-Hirschhorn Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This locus is closely linked to Huntington disease and has been mapped to chromosome 4 short arm using human-mouse somatic cell hybrids, and specifically to chromosome 4 band p16 using DNA from individuals with deletions of chromosome 4 short arm who exhibit Wolf-Hirschhorn syndrome.
|
2876628 |
1986 |
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
These findings suggest that loss or mutations of the p16 gene are involved in most esophageal cancers and that mutation of this gene plays a critical role in the development of esophageal cancer.
|
8093026 |
1994 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
These data suggest that the target of deletion in glioblastoma multiforme includes both p15 and p16 genes.
|
7987828 |
1994 |
Glioma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Here we have examined 32 glioma cell lines for amplification-associated overexpression of the CDK4 gene as an alternative mechanism for abrogating the growth-regulatory effects of p16.
|
7954404 |
1994 |
melanoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We have also sequenced exon 2 of the recently identified candidate tumour suppressor gene, p16, in six individuals and found no evidence for germline mutations in this region of the p16 gene in our families with inherited malignant melanoma.
|
7881419 |
1994 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The identical nature of mutations observed in primary tumours and metastases derived from the same patient provides strong evidence that inactivation of p16 function was an in vivo event.
|
8001221 |
1994 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Homozygous deletions of p16 were identified in 5 of 23 (22%) primary tumors; no mutations or rearrangements were found in these specimens.
|
7923195 |
1994 |
Esophageal carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that loss or mutations of the p16 gene are involved in most esophageal cancers and that mutation of this gene plays a critical role in the development of esophageal cancer.
|
8093026 |
1994 |
Adult Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We found that p16 and a neighboring gene, p15, were often homozygously deleted in glioblastoma multiformes but not in medulloblastomas or ependymomas.
|
7987828 |
1994 |
Childhood Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We found that p16 and a neighboring gene, p15, were often homozygously deleted in glioblastoma multiformes but not in medulloblastomas or ependymomas.
|
7987828 |
1994 |
Malignant neoplasm of esophagus
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that loss or mutations of the p16 gene are involved in most esophageal cancers and that mutation of this gene plays a critical role in the development of esophageal cancer.
|
8093026 |
1994 |
Hereditary Melanoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Germline p16 mutations in familial melanoma.
|
7987387 |
1994 |
Glioblastoma Multiforme
|
0.100 |
Biomarker
|
disease |
BEFREE |
These data suggest that the target of deletion in glioblastoma multiforme includes both p15 and p16 genes.
|
7987828 |
1994 |
Secondary Neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The identical nature of mutations observed in primary tumours and metastases derived from the same patient provides strong evidence that inactivation of p16 function was an in vivo event.
|
8001221 |
1994 |
Malignant mesothelioma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, deletions of 9p21-p22 outside of the p16 locus may reflect the involvement of other putative tumor suppressor genes that could also contribute to the pathogenesis of some MMs.
|
7923195 |
1994 |
Brain Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Deletion of p16 and p15 genes in brain tumors.
|
7987828 |
1994 |
Medulloblastoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
We found that p16 and a neighboring gene, p15, were often homozygously deleted in glioblastoma multiformes but not in medulloblastomas or ependymomas.
|
7987828 |
1994 |
Ependymoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
We found that p16 and a neighboring gene, p15, were often homozygously deleted in glioblastoma multiformes but not in medulloblastomas or ependymomas.
|
7987828 |
1994 |
Adenocarcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The significance of p16 mutations in gastric tumorigenesis was examined by assessing p16 mutations as well as loss of heterozygosity (LOH) on 9p in 13 gastric adenomas and 45 adenocarcinomas.
|
7775254 |
1995 |
Adenocarcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The p16 coding gene is often mutated in glioblastomas, pancreatic adenocarcinomas and melanoma-prone pedigrees, but, until recently, the significance of these allelic variants has remained unclear.
|
7566978 |
1995 |
Adenoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The significance of p16 mutations in gastric tumorigenesis was examined by assessing p16 mutations as well as loss of heterozygosity (LOH) on 9p in 13 gastric adenomas and 45 adenocarcinomas.
|
7775254 |
1995 |
Malignant neoplasm of urinary bladder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.
|
7747814 |
1995 |
Malignant neoplasm of urinary bladder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggested that p16 gene mutations, although they occurred at low frequency, are involved in some low-grade and early stage bladder cancers.
|
8747595 |
1995 |
Malignant neoplasm of urinary bladder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Alteration of the p16 and p15 genes, especially coincident homozygous deletion, appears to be a common event in bladder cancer.
|
7563186 |
1995 |